Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
7 April 2005
The European Medicines Agency (EMEA) has today announced a voluntary suspension of Bextra sales and marketing, pending the completion of the review of safety of Cox-2 inhibitors, which is ongoing.
›
Press release
›
Letter to healthcare professionals
›
Questions and answers
Voluntary suspension of Valdecoxib (Bextra) by Pfizer; questions and answers 
